Inactive Instrument

Press Releases Genomic Vision

Equities

GV

FR0011799907

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	Nov. 24	AQ
Genomic Vision : Inside Information / Other news releases	Nov. 17	PU
Genomic Vision conclut un accord de distribution avec CliniSciences	23-06-22	GL
Genomic Vision conclut un accord de distribution avec CliniSciences	23-06-22	AQ
The US National Institute of Standards and Technology (NIST) has evaluated the use of Genomic Vision applications for genetic variant characterization	23-02-21	AQ
Genomic Vision : Inside Information / Other news releases	23-01-24	PU
Genomic Vision : Inside Information / Other news releases	22-02-15	PU
Genomic Vision : Announces the Issuance of the 2nd Tranche of Convertible Notes With Warrants (OCABSA) for €1.2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million	21-03-04	BU
Genomic Vision: Financial Information for the Fourth Quarter of 2020	21-02-18	BU
Genomic Vision : Announces the Availability of the Prospectus Relating to the Financing Program Concluded With Winance for a Maximum Amount of €12 Million	21-02-09	BU
Genomic Vision : As Part of the Financing Line Concluded With Winance, Genomic Vision Announces the Issuance of the First Tranche of Convertible Notes With Warrants (OCABSA) for €0.8 Million	20-11-24	BU
Genomic Vision: Financial Information for the Third Quarter of 2020	20-11-12	BU
Genomic Vision : Signs a Distribution Agreement for Covid-19 Rapid Diagnostic Tests With Toda Pharma	20-10-13	BU
Genomic Vision: First-half 2020 Results	20-09-29	BU
Genomic Vision: Convening of Another Extraordinary General Meeting on October 30, 2020	20-09-22	BU
Genomic Vision : Announces the Approval by its General Meeting of all the Resolutions Recommended by the Management Board	20-08-10	BU
Genomic Vision: Convening of a New Combined Shareholders’ Meeting on August 10, 2020	20-07-24	BU
Genomic Vision: Financial Information for the First Half of 2020	20-07-20	BU
Genomic Vision: Implementation of a Financing Line via the Reserved Issuance of Convertible Notes With Warrants (OCABSA) for a Maximum of €12 Million, Subject to Shareholders’ Approval	20-06-15	BU
Genomic Vision: Financial Information for the First Quarter of 2020	20-05-29	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Genomic Vision

Equities

GV

FR0011799907

Press Releases

Filters